Intralesional Methotrexate for Treatment of Invasive Squamous Cell Carcinomas in a Patient Taking Vemurafenib for Treatment of Metastatic Melanoma

被引：5

作者：

Moye, Molly S. ^{[1
]}

Clark, Ashlynne H. ^{[1
]}

Legler, Allison A. ^{[1
]}

Milhem, Mohammed M. ^{[1
]}

Van Beek, Marta J. ^{[1
]}

机构：

[1] Univ Iowa, Iowa City, IA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 14期

关键词：

BRAF INHIBITOR THERAPY; NEOADJUVANT;

D O I：

10.1200/JCO.2013.50.2880

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E134 / E136

页数：3

共 13 条

[1] Photodynamic Therapy for Multiple Eruptive Keratoacanthomas Associated With Vemurafenib Treatment for Metastatic Melanoma [J].

Alloo, Allireza ;

Garibyan, Lilit ;

LeBoeuf, Nicole ;

Lin, George ;

Werchniak, Andrew ;

Hodi, F. Stephen, Jr. ;

Flaherty, Keith T. ;

Lawrence, Donald P. ;

Lin, Jennifer Y. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (03) :363-366

[2] Systemic Retinoid Therapy for Chemoprevention of Nonmelanoma Skin Cancer in a Patient Treated With Vemurafenib [J].

Anforth, Rachael ;

Blumetti, Tatiana Cristina Moraes Pinto ;

Affandi, Azura Mohd ;

Fernandez-Penas, Pablo .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (19) :E165-E167

[3] Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literature [J].

Annest, Nicole M. ;

VanBeek, Marta J. ;

Arpey, Christopher J. ;

Whitaker, Duane C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (06) :989-993

[4] Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma [J].

Boyd, Kevin P. ;

Vincent, Bethaney ;

Andea, Aleodor ;

Conry, R. Martin ;

Hughey, Lauren C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) :1375-1379

[5] Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study [J].

Chu, Emily Y. ;

Wanat, Karolyn A. ;

Miller, Christopher J. ;

Amaravadi, Ravi K. ;

Fecher, Leslie A. ;

Brose, Marcia S. ;

McGettigan, Suzanne ;

Giles, Lydia R. ;

Schuchter, Lynn M. ;

Seykora, John T. ;

Rosenbach, Misha .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) :1265-1272

[6] Intralesional agents in the management of cutaneous malignancy: A review [J].

Good, Laurie M. ;

Miller, Misha D. ;

High, Whitney A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) :413-422

[7] Dynamic Changes in Nevi of a Patient With Melanoma Treated With Vemurafenib Importance of Sequential Dermoscopy [J].

Haenssle, Holger A. ;

Kraus, Sophie L. ;

Brehmer, Franziska ;

Kretschmer, Lutz ;

Voelker, Bernward ;

Asper, Hiba ;

Kapp, Alexander ;

Gutzmer, Ralf .

ARCHIVES OF DERMATOLOGY, 2012, 148 (10) :1183-1185

[8] Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway [J].

Huang, Victor ;

Hepper, Donna ;

Anadkat, Milan ;

Cornelius, Lynn .

ARCHIVES OF DERMATOLOGY, 2012, 148 (05) :628-633

[9] Clinical trial: intralesional infiltration of methotrexate as neoadjuvant in the keratoacanthoma surgery allows to obtain better aesthetic and functional results [J].

Martorell-Calatayud, A. ;

Requena, C. ;

Nagore, E. ;

Sanmartin, O. ;

Serra-Guillen, C. ;

Botella-Estrada, R. ;

Sanz-Motilva, V. ;

Llombart, B. ;

Alcaniz-Moscardo, A. ;

Guillen-Barona, C. .

ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (08) :605-615

[10] Cutaneous effects of BRAF inhibitor therapy: a case series [J].

Mattei, P. L. ;

Alora-Palli, M. B. ;

Kraft, S. ;

Lawrence, D. P. ;

Flaherty, K. T. ;

Kimball, A. B. .

ANNALS OF ONCOLOGY, 2013, 24 (02) :530-537

← 1 2 →